Market Place
Sourcing Support
Hikma Announces Settlement Agreement For Vyndamax (Tafamidis)
28 Apr 2026 //
FIRSTWORD PHARMA
Hikma Backs Outlook on Faith in Demand, Managing Iran War
23 Apr 2026 //
REUTERS
SCOTUS to hear `skinny label` case between Amarin, Hikma
20 Jan 2026 //
FIERCE PHARMA
Hikma Affirms 2025 Guidance, Revises Growth Outlook
06 Nov 2025 //
PHARMIWEB
Hikma Receives Fda Approval for Tyzavan (vancomycin) in The Us
02 Jul 2025 //
PR NEWSWIRE
Hikma Pharmaceuticals Usa Invests $1 Billion in US Expansion
01 Jul 2025 //
FIERCE PHARMA
Axsome Therapeutics Settles Sunosi Patent Litigation with Hikma
05 Mar 2025 //
GLOBENEWSWIRE
Hikma & M42 sign strategic MoU to advance health innovation in UAE
06 Feb 2025 //
BIOSPECTRUM
Jazz, Hikma must face `reverse payment` claims over narcolepsy drug
27 Aug 2024 //
REUTERS
Hikma Participates In Naloxone Training With Congressman
20 Aug 2024 //
PR NEWSWIRE
KLOXXADO Naloxone Nasal Spray Shelf-Life Extended To 36 Months
15 Aug 2024 //
PR NEWSWIRE
After Stock crash and Staff cuts, Amarin wins bid to revive Vascepa patent
26 Jun 2024 //
FIERCE PHARMA
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
30 Mar 2024 //
FIERCE PHARMA
Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus
21 Feb 2024 //
PR NEWSWIRE
Hikma announces US launch of COMBOGESIC® IV
05 Feb 2024 //
PR NEWSWIRE
Hikma to pay $115M in cash, $35M in donations to settle opioid claims
02 Feb 2024 //
ENDPTS
Guardant Health and Hikma Partner to Offer Cancer Screening Tests
08 Jan 2024 //
BUSINESSWIRE
Hikma marks two-year anniversary of KLOXXADO® launch
03 Oct 2023 //
PR NEWSWIRE
Korea`s SK Biopharma enters MENA through strategic partnership with Hikma
21 Aug 2023 //
BIOSPECTRUM ASIA
Rakuten Medical and Hikma Sign Licensing Agreement for Alluminox Platform
10 Aug 2023 //
PR NEWSWIRE
Hikma Ventures invests in Octave Bioscience, a precision care platform
26 Jul 2023 //
PR NEWSWIRE
Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory
20 Jul 2023 //
REUTERS
Hikma exceeds 150 injectable medicines in US with launch of Dobutae Injection
15 Jun 2023 //
PR NEWSWIRE
Hikma & Junshi Biosciences sign exclusive licensing agreementfor cancer treatment drug toripalimab
27 Dec 2022 //
PRESS RELEASE
Junshi Biosciences & Hikma Sign Exclusive Licensing Agreement for Toripalimab
26 Dec 2022 //
GLOBENEWSWIRE
Corcept Therapeutics Settles Patent Litigation with Hikma Pharmaceuticals
08 Dec 2022 //
GLOBENEWSWIRE
Hikma, Teva, Sandoz Report Short Supply of Amoxicillin in US
25 Oct 2022 //
BLOOMBERG
Hikma appoints Deneen Vojta as a Director
13 Oct 2022 //
PRESS RELEASE
Glenmark`s partner Hikma launches specialty drug Ryaltris in US
30 Aug 2022 //
ECONOMICTIMES
Hikma launches RYALTRIS seasonal allergic rhinitis nasal spray in the US
30 Aug 2022 //
PRNEWSWIRE
Enforcement Report - Week of August 17, 2022
17 Aug 2022 //
FDA
Hikma completes acquisition of Custopharm
21 Apr 2022 //
PRNEWSWIRE
FTC requires Hikma to let go of steroid drug, post $375M Custopharm acquisition
20 Apr 2022 //
ENDPTS
Hikma Ventures invests in Tact.ai
29 Mar 2022 //
PRNEWSWIRE
Hikma leads Series A extension in NuvoAir for patient care and clinical trials
19 Jan 2022 //
PRNEWSWIRE
Hikma expands into Canada with acquisition of Teligent sterile injectable assets
17 Jan 2022 //
PRNEWSWIRE
Hikma launches new outsourced sterile compounding business, Hikma 503B
11 Jan 2022 //
PHARMABIZ
Hikma Beats Amarin`s `Skinny Label` Patent Suit
04 Jan 2022 //
LAW360
Richter, Hikma sign excl. commercialisation & license agreement for denosumab
09 Dec 2021 //
PRNEWSWIRE
Hikma and Almirall enter an exclusive licensing agreement to market
01 Nov 2021 //
HIKMA
Hikma donates 50,000 doses of inj naloxone to help expand non-profit access
22 Oct 2021 //
PRNEWSWIRE
Hikma launches Micafungin for Injection
12 Oct 2021 //
HIKMA
Hikma`s $425M injectables buy will face FTC scrutiny
28 Sep 2021 //
FIERCEPHARMA
Hikma and FAES Farma enter into exclusive licensing agreement
20 Sep 2021 //
PRNEWSWIRE
Bio-Thera and Hikma Announce License Agreement for BAT2206 in the US
27 Aug 2021 //
BUSINESSWIRE
AAM urges federal judge to reject challenges to “skinny label”
23 Aug 2021 //
RAPS
Hikma announces US launch of KLOXXADOâ„¢ (naloxone HCl) nasal spray 8mg
04 Aug 2021 //
PRNEWSWIRE
Hikma launches Ganciclovir for Injection, USP
22 Jun 2021 //
PRESS RELEASE
Hikma appoints Patrick Genestin to lead Generics Business Development
09 Jun 2021 //
PRNEWSWIRE
Hikma launches Hydralazine Hydrochloride Injection, USP
12 May 2021 //
DRUGSTORENEWS
Hikma announces US FDA approval of KLOXXADOTM (naloxone HCL)
29 Apr 2021 //
PRNEWSWIRE
Hikma announces exclusive agreement with AFT Pharmaceuticals for injectable
28 Apr 2021 //
PRNEWSWIRE
Hikma announces exclusive agreement with AFT Pharmaceuticals for injectable
28 Apr 2021 //
PRNEWSWIRE
Hikma Resumes Launch Of Generic Version Of GlaxoSmithKline`s Advair
20 Apr 2021 //
NASDAQ
Hikma Pledges additional $40K to local US food banks and pantries
18 Mar 2021 //
PRNEWSWIRE
Hikma provides update on generic Advair Diskus®
15 Jan 2021 //
INVESTEGATE
Sesen Bio Announces Partnership with Hikma Pharmaceuticals Vicineum™
01 Dec 2020 //
BUSINESSWIRE
Hikma continues strong 2020 performance and updates full year guidance
05 Nov 2020 //
PHARMIWEB
Hikma Pharma Launches Icosapent Ethyl Capsules In U.S. - Quick Facts
05 Nov 2020 //
NASDAQ
Hikma and Arecor expand collaboration with new agreement to develop
20 Oct 2020 //
PRNEWSWIRE
